Skip to content
Radio Logo
PodcastsHealth & WellnessLongevity by Design

Longevity by Design

InsideTracker
Latest episode

112 episodes

  • Longevity by Design

    EP #2: "Cancer Is a Disease of Mistakes" — Derek Chiang on AI, Personalized Medicine, and the Limits of Machine Learning

    11/11/2026 | 54 mins.
    In this episode of Longevity by Design, host Renée Deehan, VP of Science & Artificial Intelligence is joined by co-host Will Dzierson, VP of Product & Design, both at InsideTracker to welcome the guest Derek Chiang, VP and Head of Computational Biology at Bayer Pharmaceuticals. Renée and Derek — former Berkeley classmates — reconnect to trace how the field of computational biology has evolved from data-starved beginnings into today's AI-driven drug discovery engine. Derek walks through what personalized medicine actually means at a molecular level, using cancer as a case study for how genomic "mistakes" can be matched to targeted therapies.
  • Longevity by Design

    LBD 2.0 EP #1: Why Scientific Validity Isn't Enough

    23/10/2026 | 49 mins.
    In this episode of Longevity by Design, host Renée Deehan, Senior VP of Science, AI & Product, is joined by Will Dzierson, VP of Product & Design, both with InsideTracker, to welcome Ohad Manor, VP of Computational and Precision Health at Thorne. Ohad brings a rare perspective, having traversed academic computational biology, personalized wellness at Arivale, cancer therapeutics and diagnostics, and now consumer precision health at Thorne. The thread connecting all of it: using computation to translate complex biology into something genuinely useful for people.
  • Longevity by Design

    Do Longevity Supplements Really Work?

    30/03/2026 | 1h 9 mins.
    In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Andrea Maier, Professor in Medicine and Director of the NUS Academy for Healthy Longevity at the National University of Singapore’s School of Medicine. They explore what the evidence shows on supplements, and why “test, then treat” beats guesswork.

    Andrea unpacks a review of over 5 million people: multivitamins may support memory and lower systolic blood pressure in some older or at-risk groups, but offer little for healthy adults. She also reports lab audits of Nicotinamide Mononucleotide (NMN) and urolithin A, in which many products fell short of the label claims.

    She then sorts buzzworthy compounds like alpha-ketoglutarate, spermidine, curcumin, and melatonin by mechanism, trial quality, and fit. Her rule stays simple: measure what you can, match the dose to the need, and track outcomes with walking speed, grip strength, steps, and wearable sleep data over time, not once.

     
    Guest-at-a-Glance
    💡 Name: Dr. Andrea Maier
    💡 What she does: Professor in Medicine, Healthy Ageing and Dementia Research, and Director of the NUS Academy for Healthy Longevity
    💡 Company: the National University of Singapore’s School of Medicine
    💡 Noteworthy: She runs human trials on supplements and aging, audits label accuracy in the lab, and pushes a “measure first” approach using biomarkers, wearables, and simple strength tests.
    💡 Where to find her: https://www.linkedin.com/in/andreamaierprof
    💡 Guest Company Website: https://discovery.nus.edu.sg/19564-andrea-britta-maier

     
     
    Episode highlights:
    [00:00:00]: Introduction
    [00:01:02]: Overview of Evidence-Based Clinical Practice
    [00:02:16]: Multivitamins and Minerals: Usage and Population Trends
    [00:04:08]: Systematic Review Findings on Multivitamins and Cognitive Health
    [00:05:44]: Who Benefits Most from Multivitamin Supplementation
    [00:06:57]: Personalized Nutrition and the Case for Targeted Supplementation
    [00:08:21]: Ongoing Clinical Trials on Multivitamins and Biological Age
    [00:09:19]: Supplement Quality: Label Claims Versus Actual Content
    [00:12:14]: Navigating Supplement Quality and Consumer Guidance
    [00:14:53]: Novel Longevity Compounds: Alpha-Ketoglutarate
    [00:17:47]: Alpha-Ketoglutarate: Human Evidence and Population Focus
    [00:18:29]: Spermidine: Dietary Sources and Human Evidence
    [00:21:25]: Curcumin: Mechanisms, Evidence, and Target Populations
    [00:24:54]: Evaluating Supplements for Clinical Use
    [00:27:08]: Scientific Approach to Supplement Research
    [00:29:26]: The Role of Independent Research in Supplement Evaluation
    [00:32:37]: Melatonin: Sleep, Jet Lag, and Circadian Rhythm
    [00:37:25]: Practical Melatonin Use for Travel and Sleep Optimization
    [00:41:05]: Digital Biomarkers: Definition and Emerging Role
    [00:45:54]: Integrating Digital Biomarkers into Healthcare Practice
    [00:49:05]: Physical Function Tests: Grip Strength and Sit-to-Stand
    [00:59:48]: NAD Precursors: NMN, NR, and Human Trials
    [01:05:23]: NAD Testing: Current Landscape and Future Directions
    [01:07:24]: Final Takeaways and Closing Remarks
     

     
     
    For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast
  • Longevity by Design

    What Houses, Garbage, and Trucks Teach Us About Aging with Dr. Uri Alon

    28/03/2026 | 1h 4 mins.
    In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Uri Alon, Professor at Weizmann Institute of Science. They explore a systems view of aging that treats longevity as a solvable model, not a grab bag of disconnected theories.

    Uri explains aging with a simple story: houses make garbage, trucks remove it, and the village has a threshold for how much damage it can handle. In the body, “garbage” can include damaged and senescent cells, “trucks” can include immune cleanup, and “houses” can include long-lived cells and stem cells that drift over time. The model links this balance to death, disease, and steady decline, and it helps predict which interventions actually change it.

    They also revisit the role of genes. Uri argues that lifespan looks closer to 50% heritable today after correcting for early, non-aging deaths in older datasets. The rest comes from the environment and biological noise, which regular sleep may help reduce.
    Guest-at-a-Glance
    💡 Name: Dr. Uri Alon
    💡 What they do: Professor of Molecular Cell Biology and systems biology researcher
    💡 Company: Weizmann Institute of Science
    💡 Noteworthy: He developed the network motifs framework and uses simple models to explain aging as a balance between damage, cleanup capacity, and robustness thresholds.
    💡 Where to find him: https://www.linkedin.com/in/urialonw/

     
     
    Episode highlights:
    [00:00:00]: Introduction
    [00:01:41]: Transition from Physics to Biology and Systems Thinking
    [00:03:06]: Systems Perspective vs. Traditional Biology
    [00:03:45]: Theoretical Models and Patterns in Aging
    [00:06:29]: Network Motifs and Biological Circuits
    [00:10:26]: Applying Systems Biology to Aging and Healthspan
    [00:12:27]: The Village Model: Framework for Understanding Aging
    [00:19:24]: Interventions: Exercise, Robustness, and Lifespan Limits
    [00:22:41]: Multi-level Modeling: From High-Level to Molecular Detail
    [00:23:56]: Centenarians, Genetic Variants, and Disease Resistance
    [00:25:26]: Menopause, Aging Genes, and Rare Variants
    [00:26:57]: Heritability of Lifespan: Revisiting Twin Studies
    [00:29:23]: Lifestyle, Genetics, and Diminishing Returns
    [00:33:23]: Biological Noise, Environment, and Variability
    [00:36:23]: Developmental Stochasticity and Lifespan Differences
    [00:38:20]: Future Impact of Medicine on Genetic Influence
    [00:40:36]: Polygenic Scores, Planning, and Public Perception
    [00:41:25]: Genetic Circuits and Longevity Pathways
    [00:44:22]: Epigenetic Reprogramming vs. Senolytics
    [00:47:16]: Technological Readiness and Combining Interventions
    [00:48:44]: Other Promising Interventions: Rapamycin, Engineering, and Targeted Approaches
    [00:51:24]: GLP-1, SGLT2 Inhibitors, and Robustness
    [00:53:01]: Vascular Health, Immune Function, and Lifespan Extension
    [00:56:28]: Quick Fire Round: Myths, Principles, and Predictors
    [00:59:04]: Key Takeaways: Systems View and the Equation of Aging
    [01:02:07]: Closing Remarks and Farewell
     

     
     
    For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast
  • Longevity by Design

    Born to Live Longer? Inside the Genetics and Biology of Centenarians

    26/03/2026 | 1h 1 mins.
    In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Paola Sebastiani, Professor of Biostatistics at Tufts Clinical and Translational Science Institute. They explore what centenarians reveal about reaching 100, and why there’s no single longevity gene.

    Paola explains that studies keep finding many small genetic effects, which makes polygenic risk scores hard to use for personal prediction. She says progress depends on bigger cohorts and new analyses that include structural DNA changes and mitochondrial DNA. She also grounds the hype: for people born in 1900, only 0.2% of men and about 1% of women reached 100.

    Healthspan sits at the center of the story. Paola ties exceptional aging to delayed disease, lower inflammation, and biomarker profiles that stay more youthful. She highlights diet as a realistic lever, with centenarians showing stable, balanced eating, steadier protein intake, and metabolite signals linked to vegetables and dark chocolate.
     
     
    Guest-at-a-glance
    💡 Name: Dr. Paola Sebastiani
    💡 What they do: Professor of Biostatistics
    💡 Company: Tufts Clinical and Translational Science Institute
    💡 Noteworthy: She analyzes genetic, proteomic, and metabolomic data from centenarians to map longevity signatures, with a focus on APOE, inflammation, and delayed onset of age-related disease.
    💡 Where to find her: https://www.linkedin.com/in/paola-sebastiani-5973a646

     
    Episode highlights:
    [00:00:00]: Introduction
    [00:01:17]: Genetics and Longevity—Centenarian Studies
    [00:03:17]: Genome-Wide Association Studies and Technological Advances
    [00:04:20]: APOE, Genetic Variants, and Longevity Diversity
    [00:05:58]: Polygenic Risk Scores and Longevity Prediction
    [00:08:39]: Sample Sizes and Study Challenges in Longevity Research
    [00:11:20]: Structural Variants, Mitochondrial DNA, and Data Sharing
    [00:12:38]: Odds of Reaching Age 100—Historical Perspective
    [00:15:22]: Healthspan, Compression of Morbidity, and Centenarian Quality of Life
    [00:17:03]: Supercentenarians and Extreme Longevity
    [00:21:02]: APOE Mechanisms, Inflammation, and Proteomic Signatures
    [00:25:16]: Inflammation, Biomarkers, and Healthy Aging
    [00:29:12]: Nutrition, Diet Balance, and Longevity
    [00:32:28]: Food Versus Supplements—Practical Dietary Approaches
    [00:35:02]: Molecular Profiles—Proteomics, Metabolomics, and Lipidomics
    [00:39:01]: Gut Microbiome, Metabolomics, and Longevity Connections
    [00:41:42]: Biological Pathways and Omics Insights in Centenarians
    [00:45:01]: Protein Intake Patterns Across the Lifespan
    [00:48:23]: Environmental Factors and Longevity
    [00:50:18]: Physical Activity, Social Networks, and Objective Tracking
    [00:53:45]: Offspring of Centenarians—Inheritance and Health Outcomes
    [00:57:05]: Parental Longevity, Gender Differences, and Longevity Bias
    [01:00:43]: Key Takeaways—Aging as a Positive Process
    [01:03:25]: Closing Remarks and Episode Wrap-Up
    [01:03:41]: End of Episode
     For science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcast
    Connect with Gil on LinkedIn, Instagram, X
More Health & Wellness podcasts
About Longevity by Design
Longevity by Design is your go-to podcast for science-backed conversations on living a longer, healthier life, with honesty about what the evidence actually shows. Hosted by a rotating panel of InsideTracker leaders, including Renee Deehan, SVP of Science and AI, this show dives into cutting-edge research, addresses bias and misinformation in health, and explores the intersection of preventive medicine, AI, and health equity.In each episode, our hosts sit down with leading researchers, clinicians, and policy experts to explore how we can live better, longer lives, and make sure that science reaches everyone, not just the wealthy well. Tune in to Longevity by Design and discover how to live a longer, healthier, and more vibrant life.
Podcast website

Listen to Longevity by Design, Steph & Laura and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features